Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Eagle Pharmaceutical (EGRX)

54.16 -1.86 (-3.32%)

8/18/2017  4:00pm

Open:

55.87

Pre. Close:

56.02

High:

55.96

Low:

53.90

Volume:

342,843

Market Cap:

821.55M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

56.5 - 57.58

57.58 - 57.89

Low:

50.64 - 52.39

52.39 - 52.87

Close:

51.86 - 54.56

54.56 - 55.31

Technical analysis  (as of: 2017-08-18 4:38:42 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 76.53     One year: 91.30

Support:

Support1: 45.05    Support2: 37.48

Resistance:

Resistance1: 65.52    Resistance2: 78.17

Pivot:

51.06

Moving Averages:

MA(5): 55.12     MA(20): 53.27

MA(100): 75.53     MA(250): 73.02

MACD:

MACD(12,26): -4.04     Signal(12,26,9): -5.51

%K %D:

%K(14,3): 79.94     %D(3): 67.10

RSI:

RSI(14): 40.29

52-Week:

High: 97.15  Low: 45.05  Change(%): -9.6

Average Vol(K):

3-Month: 37477  10-Days 24599

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
EGRX has closed below upper band by 28.0%. Bollinger Bands are 10.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 26 Jul 2017 17:06:43 GMT
FDA rejects Eagle Pharmaceuticals' heat stroke treatment

Wed, 09 Aug 2017 10:41:15 GMT
Eagle Pharmaceuticals, Inc. Reports Second Quarter 2017 Results

Mon, 31 Jul 2017 10:41:15 GMT
Eagle Pharmaceuticals, Inc. to Discuss Second Quarter 2017 Financial Results ...

Thu, 17 Aug 2017 12:00:00 GMT
Trading Earnings Optimism With Options in Eagle Pharmaceuticals Inc

Fri, 11 Aug 2017 10:18:45 GMT
Generic Drugs Stock Performance Review -- Pacira Pharma, Eagle Pharma, Neos ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

15.30

Shares Float (M)

12.60

% Held by Insiders

9.79

% Held by Institutions

86.10

Shares Short (K)

3450

Shares Short Prior Month (K)

2990

Stock Financials

EPS

6.360

EPS Est. Current Year

3.380

EPS Est. Next Year

3.510

EPS Est. Next Quarter

0.820

Forward EPS

4.220

Book Value (p.s.)

10.940

PEG Ratio

0.93

Profit Margin

44.48

Operating Margin

37.55

Return on Assets (ttm)

31.4

Return on Equity (ttm)

81.3

Qtrly Rev. Growth

159.5

Gross Profit (p.s.)

8.770

Sales Per Share

EBITDA (p.s.)

5.942

Qtrly Earnings Growth

Operating Cash Flow (M)

37.66

Levered Free Cash Flow (M)

-1.80

FoxReading.com

Valuation

P/E

8.52

P/E Growth Ratio

-0.03

P/BV

4.95

P/S

54054012.00

P/CF

22.00

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.